Who is sponsoring NCT03487159?

NCT03487159 is sponsored by Prof. Ziv Ben-Ari MD.

What drugs are being tested in NCT03487159?

Interventions in NCT03487159: MRE (Magnetic Resonance Elastography).

What condition does NCT03487159 study?

NCT03487159 studies Liver Diseases.

Is NCT03487159 still recruiting?

NCT03487159 is currently status unknown. Last updated 3 April 2018.

Last reviewed 2018-04-03 · How we verify

NCT03487159

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis Stage

Status unknown NA Last updated 3 April 2018

What this trial tests

NA trial testing MRE (Magnetic Resonance Elastography) in Liver Diseases in 140 participants. Status unknown.

Timeline

1 May 2018

Primary endpoint
1 May 2019

1 June 2019

Quick facts

Lead sponsor	Prof. Ziv Ben-Ari MD
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	140
Start date	1 May 2018
Primary completion	1 May 2019
Estimated completion	1 June 2019
Sites	1 location across Israel

Drugs / interventions tested

MRE (Magnetic Resonance Elastography)

Conditions studied

Liver Diseases — all drugs for Liver Diseases →

Sponsor

Prof. Ziv Ben-Ari MD

Who can join

Adults 18 to 100, any sex, with Liver Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the ability of Magnetic Resonance Elastography non invasive technology to identify the liver fibrosis stage in patients with chronic liver diseases compared to Shear Wave Elastography and/or Liver Biopsy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Liver Diseases

Currently open trials in the same condition.

NCT07400289 — Development of a FibroScan Liver Examination Using a Single Probe · NA · recruiting
NCT07150624 — The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine · Phase 4 · recruiting
NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
NCT06874296 — Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time · NA · recruiting
NCT07053488 — CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection · Phase 1, PHASE2 · recruiting

Other Prof. Ziv Ben-Ari MD trials

Trials by the same sponsor.

NCT03492879 — Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03487159 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. Ziv Ben-Ari MD
Last refreshed: 3 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03487159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing